Literature DB >> 6381637

Physiology of B cells in mice with X-linked immunodeficiency (xid). III. Disappearance of xid B cells in double bone marrow chimeras.

J Sprent, J Bruce.   

Abstract

Evidence is presented that B cells from mice with X-linked immunodeficiency (xid) differentiate at a slower rate than normal B cells. This conclusion stems from studies in which (B6 X CBA/J)F1 mice were heavily irradiated (1,000 rads) and reconstituted with a mixture of T-depleted marrow cells taken from (a) nondefective B6 mice (H-2b) and (b) xid CBA/N or nondefective CBA/Ca mice (both H-2k). With transfer of CBA/Ca plus B6 marrow cells, the irradiated recipients become repopulated with B cells derived from both parental marrow sources; except for an early imbalance (probably reflecting Hh resistance), the degree of chimerism remained relatively stable over a period of more than 6 months. Very different results occurred with transfer of a mixture of xid CBA/N and normal B6 marrow. Within the first 2 months after marrow reconstitution, a low but significant proportion of the B cells in both spleen and lymph nodes were of CBA/N origin. Thereafter the proportion of these cells fell progressively, and by 6-9 months virtually all of the B cells were of B6 origin. This gradual decline in CBA/N-derived cells did not apply to other cell types, i.e., T cells or pluripotential stem cells. Analogous results were obtained with transfer of CBA/N vs. CBA/Ca marrow cells into sublethally irradiated (750 rads) (CBA/N X DBA/2)F1 male vs. female mice. For example, CBA/N-marrow derived B cells differentiated effectively and survived for long periods in F1 male mice (xid----xid) but not in F1 female mice (xid----normal). The finding that xid B cells eventually disappear in the presence of normal B cells strengthens the view that xid B cells are an abnormal population not represented in normal mice.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6381637      PMCID: PMC2187403          DOI: 10.1084/jem.160.3.711

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  Antitrinitrophenyl (TNP) plaque assay. Primary response of Balb/c mice to soluble and particulate immunogen.

Authors:  M B Rittenberg; K L Pratt
Journal:  Proc Soc Exp Biol Med       Date:  1969-11

Review 2.  The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity.

Authors:  I Scher
Journal:  Adv Immunol       Date:  1982       Impact factor: 3.543

3.  Functional heterogeneity of the Lyb-5- B cell subpopulation: mutant xid B cells and normal Lyb-5- B cells differ in their responsiveness to phenol-extracted lipopolysaccharide.

Authors:  S Ono; L J Yaffe; J L Ryan; A Singer
Journal:  J Immunol       Date:  1983-05       Impact factor: 5.422

Review 4.  B cell differentiation antigens as probes for functional B cell subsets.

Authors:  B T Huber
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

5.  Physiology of B cells in mice with X-linked immunodeficiency. II. Influence of the thymus and mature T cells on B cell differentiation.

Authors:  J Sprent; J Bruce
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

6.  Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes.

Authors:  J F Miller; G F Mitchell
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

7.  Negative selection in vivo reveals expression of strong Mls determinants in mice with X-linked immunodeficiency.

Authors:  S R Webb; D E Mosier; D B Wilson; J Sprent
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

8.  Tolerance to histocompatibility determinants in tetraparental bone marrow chimeras.

Authors:  H Boehmer; J Sprent; M Nabholz
Journal:  J Exp Med       Date:  1975-02-01       Impact factor: 14.307

9.  Role of the thymus in directing the development of a subset of B lymphocytes.

Authors:  J J Mond; I Scher; J Cossman; S Kessler; P K Mongini; C Hansen; F D Finkelman; W E Paul
Journal:  J Exp Med       Date:  1982-03-01       Impact factor: 14.307

10.  Unbalanced X chromosome mosaicism in B cells of mice with X-linked immunodeficiency.

Authors:  M H Nahm; J W Paslay; J M Davie
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

View more
  15 in total

Review 1.  BAFF and the plasticity of peripheral B cell tolerance.

Authors:  Jason E Stadanlick; Michael P Cancro
Journal:  Curr Opin Immunol       Date:  2008-05-02       Impact factor: 7.486

Review 2.  Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires.

Authors:  C C Goodnow
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

3.  The B lymphocyte-specific coactivator BOB.1/OBF.1 is required at multiple stages of B-cell development.

Authors:  J Hess; P J Nielsen; K D Fischer; H Bujard; T Wirth
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

4.  Nonrandom X chromosome inactivation in B cells from carriers of X chromosome-linked severe combined immunodeficiency.

Authors:  M E Conley; A Lavoie; C Briggs; P Brown; C Guerra; J M Puck
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

Review 5.  Signalling crosstalk in B cells: managing worth and need.

Authors:  Michael P Cancro
Journal:  Nat Rev Immunol       Date:  2009-09       Impact factor: 53.106

Review 6.  Manipulating B cell homeostasis: a key component in the advancement of targeted strategies.

Authors:  Laura S Treml; William J Quinn; John F Treml; Jean L Scholz; Michael P Cancro
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2008-05-30       Impact factor: 4.291

7.  Akt1 and Akt2 promote peripheral B-cell maturation and survival.

Authors:  Marco Calamito; Marisa M Juntilla; Matthew Thomas; Daniel L Northrup; Jeffrey Rathmell; Morris J Birnbaum; Gary Koretzky; David Allman
Journal:  Blood       Date:  2009-12-30       Impact factor: 22.113

8.  Naturally occurring Bruton's tyrosine kinase mutations have no dominant negative effect in an X-linked agammaglobulinaemia cellular model.

Authors:  R Pérez de Diego; E López-Granados; J Rivera; A Ferreira; G Fontán; J Bravo; M C García Rodríguez; S Bolland
Journal:  Clin Exp Immunol       Date:  2008-01-28       Impact factor: 4.330

9.  Modulation of B-cell abnormalities in lupus-prone (NZB x NZW)F1 mice by normal bone marrow-derived B-lineage cells.

Authors:  D Z Shao; S Yamada; F Hirayama; H Hirano; S Ono; T Hamaoka
Journal:  Immunology       Date:  1995-05       Impact factor: 7.397

10.  Strain variation in the frequency of Abelson murine leukemia virus-transformed fetal liver pre-B cells bearing complete immunoglobulin heavy chain rearrangements.

Authors:  G E Osman; H H Wortis; P H Brodeur
Journal:  J Exp Med       Date:  1988-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.